It has been experimentally demonstrated that the standardized aRVS extract has antiangiogenic activities by inhibiting VEGF and an inhibitory effect on matrix metalloproteinase-2 (MMP-2) and MMP-9 activities in a human fibrosarcoma cell line [35, 36]. Here, MMP9 is linked to fibrosarcoma.